Exhaled nitric oxide (F ENO) in non-pulmonary diseases

Journal of Breath Research

Volumn 6, Issue 2, 2012, Pages

  Bucca, Caterina ^a   Cicolin, Alessandro ^a   Guida, Giuseppe ^a   Heffler, Enrico ^a   Brussino, Luisa ^a   Rolla, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; BIOLOGICAL MARKER;

ALTITUDE DISEASE; CARDIOVASCULAR DISEASE; DISEASE MARKER; DISEASES; ENTERITIS; EXPIRED AIR; HEPATOPULMONARY SYNDROME; HUMAN; LYMPHOPROLIFERATIVE DISEASE; NON PULMONARY DISEASE; PATHOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SLEEP APNEA SYNDROME; SYSTEMIC SCLEROSIS; BREATH ANALYSIS; DIGESTIVE SYSTEM DISEASE; EXHALATION; METABOLISM; METHODOLOGY; REPRODUCIBILITY; SLEEP DISORDERED BREATHING;

ALTITUDE SICKNESS; BIOLOGICAL MARKERS; BREATH TESTS; CARDIOVASCULAR DISEASES; DIGESTIVE SYSTEM DISEASES; EXHALATION; HUMANS; NITRIC OXIDE; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC; SLEEP APNEA, OBSTRUCTIVE;

EID: 84861474658     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/6/2/027104     Document Type: Review

References (54)

1. Gustafsson L E, Leone A M, Persson M G, Wiklund N P and Moncada S 1991 Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans Biochem. Biophys. Res. Commun. 181 852-7
2. American Thoracic Society 1999 Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children Am. J. Respir. Crit. Care Med. 160 2104-17
3. Ozkan M and Dweik R A 2001 Nitric oxide and airway reactivity Clin. Pulm. Med. 8 199-206
4. Kharitonov S A, Yates D, Robbins R A, Logan-Sinclair R, Shinebourne E A and Barnes P J 1994 Increased nitric oxide in exhaled air of asthmatic patients Lancet 343 133-5 (Pubitemid 24028638)
5. Barnes P J et al 2010 Exhaled nitric oxide in pulmonary diseases: a comprehensive review Chest 138 682-92
6. Griffith T M, Lewis M J, Newby A C and Henderson A H 1988 Endothelium-derived relaxing factor J. Am. Coll. Cardiol. 12 797-806
7. Dweik R A, Laskowski D, Abu-Soud H M, Kaneko F, Hutte R, Stuehr D J and Erzurum S C 1998 Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism J. Clin. Invest. 101 660-6 (Pubitemid 28084250)
8. Dweik R A 2002 Pulmonary hypertension and the search for the selective pulmonary vasodilator Lancet 360 886-7
9. Katz S D, Khan T, Zeballos G A, Mathew L, Potharlanka P, Knecht M and Whelan J 1999 Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure Circulation 99 2113-7 (Pubitemid 29196794)
10. Sumino H, Sato K, Sakamaki T and Masuda H 1998 Decreased basal production of nitric oxide in patients with heart disease Chest 113 317-22 (Pubitemid 28110004)
11. Hare J M, Nguyen G C, Massaro A F, Drazen J M, Stevenson L W, Colucci W S, Fang J C, Johnson W, Givertz M M and Lucas C 2002 Exhaled nitric oxide: a marker of pulmonary hemodynamics in heart failure J. Am. Coll. Cardiol. 40 1114-9
12. Agostoni P and Bussotti M 2003 Exhaled nitric oxide and exercise performance in heart failure Arch. Physiol. Biochem. 111 293-6 (Pubitemid 40292062)
13. Rolla G, Mangiardi L, Bucca C, Costanzo P, Casoni R, Omedè P L, Brussino L and Morello M 2003 Exhaled nitric oxide during exercise and dobutamine stress echocardiography in patients with mitral stenosis Eur. J. Int. Med. 14 166-71 (Pubitemid 36677612)
14. Katz S D, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A and Yasskiy A 2005 Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure Circulation 111 310-4 (Pubitemid 40165337)
15. Guazzi M, Agostoni P G, Matturri M, Pontone G and Guazzi M D 1999 Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol Am. Heart J. 138 460-7 (Pubitemid 29428768)
16. Hoit B D, Dalton N D, Erzurum S C, Laskowski D, Strohl K P and Beall C M 2005 Nitric oxide and cardiopulmonary hemodynamics in Tibetan highlanders J. Appl. Physiol. 99 1796-801 (Pubitemid 41547177)
17. Donnelly J, Cowan D C, Yeoman D J, Lucas S J E, Herbison G P, Thomas K N, Ainslie P N and Taylor D R 2011 Exhaled nitric oxide and pulmonary artery pressures during graded ascent to high altitude Respir. Physiol. Neurobiol. 177 213-7
18. Busch T, Bärtsch P, Pappert D, Grünig E, Hildebrandt W, Elser H, Falke K J and Swenson E R 2001 Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high altitude pulmonary edema Am. J. Respir. Crit. Care Med. 163 368-73 (Pubitemid 32158514)
19. Duplain H, Sartori C, Lepori M, Egli M, Allemann Y, Nicod P and Scherrer U 2000 Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation Am. J. Respir. Crit. CareMed. 162 221-4 (Pubitemid 30469824)
20. Vinnikov D, Brimkulov N, Redding-Jones R and Jumabaeva K 2011 Exhaled nitric oxide is reduced upon chronic intermittent hypoxia exposure in well acclimatized mine workers Respir. Physiol. Neurobiol. 175 261-4
21. Giaid A and Saleh D 1995 Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension N Engl. J. Med. 333 214-21
22. Cremona G, Higenbottam T W, Bower E A, Wood A M and Stewart S 1999 Hemodynamic effects of basal and stimulated release of endogenous nitric oxide in isolated human lungs Circulation 100 1316-21 (Pubitemid 29440125)
23. Kaneko F T, Arroliga A C, Dweik R A, Comhair S A, Laskowski D, Oppedisano R, Thomassen M J and Erzurum S C 1998 Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension Am. J. Respir. Crit. Care Med. 158 917-23 (Pubitemid 28449461)
24. Dweik R A 2007 The lung in the balance: arginine, methylated arginines, and nitric oxide Am. J. Physiol. Lung Cell Mol. Physiol. 292 L15-7 (Pubitemid 46103425)
25. Girgis R E, Champion H C, Diette G B, Johns R A, Permutt S and Sylvester J T 2005 Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy Am. J. Respir. Crit. Care Med. 172 352-7 (Pubitemid 41026146)
26. Malinovschi A, Henrohn D, Eriksson A, Lundberg J O, Alving K and Wikstro G 2011 Increased plasma and salivary nitrite and decreased bronchial contribution to exhaled NO in pulmonary arterial hypertension Eur. J. Clin. Invest. 41 889-97
27. Ozkan M, Dweik R A, Laskowski D, Arroliga A C and Erzurum S C 2001 High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy Lung 179 233-43 (Pubitemid 34194207)
28. Lavie L, Hefetz A, Luboshitzky R, Luboshitzky R and Lavie P 2003 Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment J. Mol. Neurosci. 21 57-63 (Pubitemid 37204873)
29. Foresi A, Leone C, Olivieri D and Cremona G 2007 Alveolar-derived exhaled nitric oxide is reduced in obstructive sleep apnea syndrome Chest 132 860-7
30. Depalo A, Carpagnano G E, Spanevello A, Sabato R, Cagnazzo M G, Gramiccioni C and Foschino-Barbaro M P 2008 Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects J. Intern. Med. 263 70-8 (Pubitemid 350243547)
31. Carpagnano G E, Spanevello A, Sabato R, Depalo A, Turchiarelli V and Foschino Barbaro M P 2008 Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome Transl. Res. 151 45-50 (Pubitemid 350167045)
32. Olopade C O, Christon J A, Zakkar M, Hua C, Swedler W I, Scheff P A and Rubinstein I 1997 Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea Chest 111 1500-4 (Pubitemid 27260072)
33. Bucca C et al 2011 Clinical and functional prediction of moderate to severe obstructive sleep apnea Clin. Respir. J. 5 219-6
34. Culla B, Guida G, Brussino L, Tribolo A, Cicolin A, Sciascia S, Badiu I, Mietta S and Bucca C 2010 Increased oral nitric oxide in obstructive sleep apnoea Respir. Med. 104 316-20
35. Matsumoto A, Ogura K, Hirata Y, Kakoki M, Watanabe F, Takenaka K, Shiratori Y, Momomura S and Omata M 1995 Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis Ann. Intern. Med. 123 110-3
36. Rolla G et al 1997 Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis Hepatology 26 842-7 (Pubitemid 27413646)
37. Delclaux C, Mahut B, Zerah-Lancner F, Delacourt C, Laoud S, Cherqui D, Duvoux C, Mallat A and Harf A 2002 Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma Am. J. Respir. Crit. Care Med. 165 332-7 (Pubitemid 34118504)
38. Rolla G, Brussino L, Colagrande P, Scappaticci E, Morello M, Bergerone S, Ottobrelli A, Cerutti E, Polizzi S and Bucca C 1998 Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation Ann. Intern. Med. 129 375-8 (Pubitemid 28402792)
39. Rolla G, Bucca C and Brussino L 1994 Methylene blue in the hepatopulmonary syndrome N Engl. J. Med. 331 1098
40. Schenk P, Madl C, Rezaie-Majd S, Lehr S and Muller C 2000 Methylene blue improves the hepatopulmonary syndrome Ann. Intern. Med. 133 701-6
41. Brussino L, Bucca C, Morello M, Scappaticci E, Mauro M and Rolla G 2003 Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome Lancet 362 43-4 (Pubitemid 36835821)
42. Gómez F P, Barberà J A, Roca J, Burgos F, Gistau C and Rodŕguez-Roisin R 2006 Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome Hepatology 43 1084-91
43. Zhang J, Ling Y, Luo B, Tang L, Ryter S W, Stockard C R, Grizzle W E and Fallon M B 2003 Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome Gastroenterology 125 1441-51 (Pubitemid 37409764)
44. Rolla G 2003 Is nitric oxide the ultimate mediator in hepatopulmonary syndrome? J. Hepatol. 38 668-70 (Pubitemid 36560653)
45. Koek G H, Verleden G M, Evenepoel P and Rutgeerts P 2002 Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement? Respir. Med. 96 530-5
46. ENO) for the diagnosis of pulmonary involvement due to inflammatory bowel disease Inflamm. Bowel Dis. 16 670-6
47. Lundberg J O, Hellström P M, Lundberg J M and Alving K 1994 Greatly increased luminal nitric oxide in ulcerative colitis Lancet 344 1673-4 (Pubitemid 24371099)
48. Bogdan C, Rollinghoff M and Diefenbach A 2000 The role of nitric oxide in immunity Immunol. Rev. 173 17-26
49. Nagy G, Clark J M, Buzás E I, Gorman C L and Cope A P 2007 Nitric oxide, chronic inflammation and autoimmunity Immunol. Lett. 111 1-5 (Pubitemid 47017476)
50. Guida G et al 2009 Exhaled nitric oxide and nitric oxide synthase expression in Hodgkin's disease Int. J. Immunopathol. Pharmacol. 22 1027-34
51. Wuttge D M, Bozovic G, Hesselstrand R, Aronsson D, Bjermer L, Scheja A and Tufvesson E 2010 Increased alveolar nitric oxide in early systemic sclerosis Clin. Exp. Rheumatol. 28 (Suppl. 62) S5-9
52. Tiev K P, Hua-Huy T, Kettaneh A, Allanore Y, Le-Dong N N, Duong-Quy S, Cabane J and Dinh-Xuan A T 2012 Alveolar concentration of nitric oxide predicts pulmonary function deterioration in scleroderma Thorax 67 157-63
53. Malerba M, Radaeli A, Ragnoli B, Airo' P, Corradi M, Ponticiello A, Zambruni A and Grassi V 2007 Exhaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement Chest 132 575-80
54. Rolla G et al 2000 Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension J Rheumatol. 27 1693-8 (Pubitemid 30462813)